Table 1.

Patient characteristics and Quality of life rating

Group	ADT n = 15	Control n = 15
Age	69.0 ± 5.3 y	66.1 ± 6.2 y
Education	9th grade: 1	9th grade: 1
	High School/GED: 5	High School/GED: 5
	College 1-3 years: 3	College 1-3 years: 3
	College graduate: 2	College graduate: 3
	Post-graduate: 4	Post-graduate: 3
MMSE	29.0 ± 1.3	29.5 ± 0.6
Cancer staging	Stage II: 13	Stage I: 1
	Stage III: 2	Stage II: 12
		Stage III: 2
Local therapy	Radiation 100%	Radiation 26.7%
		Surgery 66.7%
		Surgery + Radiation 6.7%
QOL at baseline	115 ± 22	132 ± 18
QOL of life at 6 months	110 ± 23	128 ± 21
Testosterone at 6 months	0.14 ± 0.10 ng/ml	2.84 ± 0.94 ng/ml

Note: ADT: Androgen Deprivation Therapy; GED: General Education Development Test; MMSE: Mini Mental State Examination; QOL: FACT-P quality of life score; there is no difference between groups in age (t = 1.172, p = 0.588, two-sided two-sample t test); there is no difference between groups in MMSE score (t = 1.417, p = 0.167, two-sided two-sample t test); staging follows the current guidelines of the 2010 American Joint Committee on Cancer (AJCC) that include Gleason score in the staging; there is also no difference across the two time points in the change of QOL between groups (F = 0.056, p = 0.814, interaction, repeated measures analysis of variance).